open access

Vol 26, No 5 (2019)
BRIEF COMMUNICATION - CLINICAL CARDIOLOGY
Published online: 2019-11-06
Get Citation

Prevalence of United States adults with triglycerides ≥ 135 mg/dL: NHANES 2007–2014

Wenjun Fan, Sephy Philip, Peter P. Toth, Craig Granowitz, Nathan D. Wong
DOI: 10.5603/CJ.2019.0099
·
Pubmed: 31701510
·
Cardiol J 2019;26(5):604-606.

open access

Vol 26, No 5 (2019)
BRIEF COMMUNICATION - CLINICAL CARDIOLOGY
Published online: 2019-11-06

Abstract

n/a - brief communication

Abstract

n/a - brief communication

Get Citation
About this article
Title

Prevalence of United States adults with triglycerides ≥ 135 mg/dL: NHANES 2007–2014

Journal

Cardiology Journal

Issue

Vol 26, No 5 (2019)

Pages

604-606

Published online

2019-11-06

DOI

10.5603/CJ.2019.0099

Pubmed

31701510

Bibliographic record

Cardiol J 2019;26(5):604-606.

Authors

Wenjun Fan
Sephy Philip
Peter P. Toth
Craig Granowitz
Nathan D. Wong

References (9)
  1. Jellinger PS, Handelsman Y, Rosenblit PD, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease: executive summary. Endocr Pract. 2017; 23(4): 479–497.
  2. Schwartz GG, Abt M, Bao W, et al. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins. J Am Coll Cardiol. 2015; 65(21): 2267–2275.
  3. Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis. JAMA Intern Med. 2016; 176(12): 1834–1842.
  4. Bhatt DL, Steg PG, Miller M, et al. REDUCE-IT Investigators. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019; 380(1): 11–22.
  5. Toth PP, Granowitz C, Hull M, et al. High triglycerides are associated with increased cardiovascular events, medical costs, and resource use: a real-world administrative claims analysis of statin-treated patients with high residual cardiovascular risk. J Am Heart Assoc. 2018; 7(15): e008740.
  6. Toth P, Philip S, Hull M, et al. Association of elevated triglycerides with increased cardiovascular risk and direct costs in statin-treated patients. Mayo Clinic Proceedings. 2019.
  7. American Diabetes Association® issues critical updates to the 2019 standards of medical care in diabetes Arlington, VA2019. http://www.diabetes.org/newsroom/press-releases/2019/ada-issues-critical-updates-to-2019-standards-of-care.html (Accessed April 11, 2019).
  8. National Health and Nutrition Examination Survey. 2007-2008 Laboratory Procedures Manual. Atlanta, GA: Center for Disease Control and Prevention; 2007.
  9. Fan W, Philip S, Granowitz C, et al. Hypertriglyceridemia in statin-treated US adults: the National Health and Nutrition Examination Survey. J Clin Lipidol. 2019; 13(1): 100–108.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl